MoCD

Health

Successful therapy confirmed for newborns with the fatal metabolic disorder MoCD type A

The drug fosdenopterin/rcPMP considerably improves the chances of survival and developmental progress in infants with molybdenum cofactor deficiency (MoCD type…

Read More »
Back to top button